Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions.
Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20% are blind. The incidence of eye lesions has been reported to be as high as 30% in Central America and parts of Africa.
A genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum.
A species of parasitic nematodes widely distributed throughout central Africa and also found in northern South America, southern Mexico, and Guatemala. Its intermediate host and vector is the blackfly or buffalo gnat.
A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.
Several species of the genus Simulium (family Simuliidae) that act as intermediate hosts (vectors) for the parasitic disease ONCHOCERCIASIS.
Pharmacological agents destructive to nematodes in the superfamily Filarioidea.
The prelarval stage of Filarioidea in the blood and other tissues of mammals and birds. They are removed from these hosts by blood-sucking insects in which they metamorphose into mature larvae.
Drugs used to treat or prevent parasitic infections.
Skin diseases caused by ARTHROPODS; HELMINTHS; or other parasites.
Infection with nematodes of the genus MANSONELLA. Symptoms include pruritus, headache, and articular swelling.
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice.
The geographical area of Africa comprising BENIN; BURKINA FASO; COTE D'IVOIRE; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; and TOGO.
An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
A parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly (Tabanus) or the deerfly or mango fly (Chrysops). The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless.
A genus of parasitic nematodes found throughout the rain-forest areas of the Sudan and the basin of the Congo. L. loa inhabits the subcutaneous tissues, which it traverses freely.
Agents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.
Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.
A republic in western Africa, south of GUINEA and east of COTE D'IVOIRE. Its capital is Monrovia.
A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC and west of NIGERIA. The capital is Yaounde.
A republic in western Africa, south of SENEGAL and MALI, east of GUINEA-BISSAU. Its capital is Conakry.
Immunoglobulins produced in a response to HELMINTH ANTIGENS.
Diseases affecting the eye.
Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.
The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)
The reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.
A republic in western Africa, lying between GHANA on its west and BENIN on its east. Its capital is Lome.
Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).
I'm sorry for any confusion, but "Ecuador" is a country in South America and not a medical term. The term you might be looking for is "ecdysone," which is a hormone found in arthropods that controls their molting process.
A republic in western Africa, south of GUINEA and west of LIBERIA. Its capital is Freetown.
A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui.
A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja.
Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.
Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis.
The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
Measure of the number of the PARASITES present in a host organism.
A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
Termination of all transmission of infection by global extermination of the infectious agent through surveillance and containment (From Porta, A Dictionary of Epidemiology, 5th ed).
I'm afraid there seems to be a misunderstanding - "Africa" is not a medical term and does not have a medical definition. Africa is the world's second-largest and second-most populous continent, consisting of 54 countries with diverse cultures, peoples, languages, and landscapes. If you have any questions related to medical topics or definitions, I would be happy to help answer those for you!
The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.
A country in western Africa, east of MAURITANIA and south of ALGERIA. Its capital is Bamako. From 1904-1920 it was known as Upper Senegal-Niger; prior to 1958, as French Sudan; 1958-1960 as the Sudanese Republic and 1959-1960 it joined Senegal in the Mali Federation. It became an independent republic in 1960.
The bestowing of tangible or intangible benefits, voluntarily and usually without expectation of anything in return. However, gift giving may be motivated by feelings of ALTRUISM or gratitude, by a sense of obligation, or by the hope of receiving something in return.
Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.
A genus of bacteria comprised of a heterogenous group of gram-negative small rods and coccoid forms associated with arthropods. (From Bergey's Manual of Systematic Bacteriology, vol 1, 1984)
A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra.
A superfamily of nematodes of the suborder SPIRURINA. Its organisms possess a filiform body and a mouth surrounded by papillae.
Deoxyribonucleic acid that makes up the genetic material of helminths.
A filarial nematode parasite of mammalian blood with the vector being a tick or small fly.
An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA).
Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
Infections or infestations with parasitic organisms. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.
A genus of parasitic nematodes whose organisms are distributed in Central and South America. Characteristics include a smooth cuticle and an enlarged anterior end.
Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.
I'm sorry for any confusion, but "Guatemala" is not a medical term and does not have a medical definition. Guatemala is the name of a country located in Central America, known officially as the Republic of Guatemala. If you have any questions related to medical topics or definitions, I would be happy to help with those!
An antischistosomal agent that has become obsolete.
The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined.
A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.
Infection of humans or animals with hookworms of the genus NECATOR. The resulting anemia from this condition is less severe than that from ANCYLOSTOMIASIS.

Candidate parasitic diseases. (1/361)

This paper discusses five parasitic diseases: American trypanosomiasis (Chagas disease), dracunculiasis, lymphatic filariasis, onchocerciasis and schistosomiasis. The available technology and health infrastructures in developing countries permit the eradication of dracunculiasis and the elimination of lymphatic filariasis due to Wuchereria bancrofti. Blindness due to onchocerciasis and transmission of this disease will be prevented in eleven West African countries; transmission of Chagas disease will be interrupted. A well-coordinated international effort is required to ensure that scarce resources are not wasted, efforts are not duplicated, and planned national programmes are well supported.  (+info)

Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic. (2/361)

The occurrence of epileptic seizures during onchocercal infestation has been suspected. Epidemiologic studies are necessary to confirm the relation between onchocerciasis and epilepsy. A matched case-control study was conducted in dispensaries of three northwestern towns of the Central African Republic. Each epileptic case was matched against two nonepileptic controls on the six criteria of sex, age (+/-5 years), residence, treatment with ivermectin, date of last ivermectin dose, and the number of ivermectin doses. Onchocerciasis was defined as at least one microfilaria observed in iliac crest skin snip biopsy. A total of 561 subjects (187 cases and 374 controls) were included in the study. Of the epileptics, 39.6% had onchocerciasis, as did 35.8% of the controls. The mean dermal microfilarial load was 26 microfilariae per mg of skin (standard deviation, 42) in the epileptics and 24 microfilariae per mg of skin (standard deviation, 48) in the controls. This matched case-control study found some relation (odds ratio = 1.21, 95% confidence interval 0.81-1.80), although it was nonstatistically significant.  (+info)

Knowledge, attitudes and practices during a community-level ivermectin distribution campaign in Guatemala. (3/361)

Community acceptance and participation are essential for the success of mass ivermectin chemotherapy programmes for onchocerciasis (river blindness). To explore the local understanding of the purpose of ivermectin and willingness to continue taking the drug, we performed questionnaire surveys in four communities with hyperendemic onchocerciasis after each of three ivermectin treatment rounds. More than 100 respondents participated in each KAP survey, representing the heads of 30% of the households in each community. The respondents rarely stated that the goal of the ivermectin treatment programme was to prevent visual loss. Instead, they said they were taking the drug for their general well-being, to cure the onchocercal nodule (filaria), or to cure the microfilaria, a term newly introduced by agents of the treatment programme. The principal reason identified for refusal to take ivermectin was anxiety about drug-related adverse reactions, and there were marked differences between communities in acceptance of treatment. In one community over 50% of residents initially refused to take ivermectin, although participation rates improved somewhat after programmatic adjustments. We recommend that ivermectin distribution programmes establish surveillance activities to detect where acceptance is poor, so that timely and community-specific adjustments may be devised to improve participation.  (+info)

Maintaining compliance to ivermectin in communities in two West African countries. (4/361)

We have investigated various aspects related to managing wide-scale ivermectin distribution schemes within randomized controlled trials in communities where onchocerciasis is endemic. Multiple logistic regression analysis of determinants of compliance to five doses of ivermectin in 589 people in Sierra Leone showed independent significant associations with leopard skin depigmentation, the severity of side effects of treatment, fulfilling the exclusion criteria for treatment, and long-term residence in the community. These results are useful for tailoring health promotion messages in Sierra Leone, but the associations may differ in other West African societies. In Nigeria 1847 people were interviewed about various subjective responses, including itching. None of these showed clear improvement after three years of ivermectin treatment. Positive comments about treatment were generally non-specific and similar in the placebo and ivermectin groups. Negative comments were usually related to adverse reactions, especially itching and rash, and were more common after ivermectin. The lack of any benefit attributable to ivermectin that is discernible to its recipients may make it difficult to maintain the high compliance rates needed for long periods if mass dosing programmes are to have a lasting impact on onchocerciasis. In addition, no consistent effects of ivermectin were found by measuring visual acuity, height, weight or haematocrit in comparison with placebo. This may indicate that evidence of clinical impact is very slow to develop and is hard to measure using simple objective methods after only three doses of treatment. At present it seems that parasitological, entomological and detailed ophthalmological or dermatological methods are required to demonstrate the impact of ivermectin treatment in the medium-term.  (+info)

Ivermectin distribution using community volunteers in Kabarole district, Uganda. (5/361)

Ivermectin mass distribution for the control of onchocerciasis in Uganda began in 1991. This report describes a community based ivermectin distribution programme covering two foci in the Kabarole district which have an estimated 32,000 persons infected and another 110,000 at risk. Through nodule palpation in adult males, 143 villages were identified where nodule prevalence exceeded 20%. Skin snips were also taken from a sample of the population to measure changes in community microfilarial load (CMFL) with treatment. The delivery programme was integrated into the district health management structure, and used community volunteers supervised by medical assistants from adjacent health facilities for annual ivermectin distribution campaigns. After initial efforts by the community to support distributors in-kind proved inadequate, ivermectin distributors earned money retailing condoms as part of the social marketing component of district STD/AIDS programme. Reduction in the CMFL ranged from 40-62% twelve months after the second ivermectin treatment in three villages, and from 69-84% six months after the fourth round of treatment in two villages. After four years of treatment, 85% of eligible persons were receiving ivermectin from community volunteers in each treatment cycle. Drop out rates among volunteers did not exceed 20% over the four years reported here. The direct cost of treatment was US $0.29 per person. Among the reasons for low per-person treatment costs were the strong supervisory structure, the presence of health centres in the foci and a well developed and capable district Primary Health Care management team.  (+info)

Independent evaluation of onchocerciasis rapid assessment methods in Benue State, Nigeria. (6/361)

OBJECTIVE: To evaluate the prevalence of palpable nodules or skin depigmentation as rapid indicators of onchocerciasis epidemicity in at-risk communities. METHOD: We examined data collected in Benue State on 11035 individuals in 32 villages to evaluate these rapid assessment methods. RESULTS: The prevalence of palpable nodules correlates more closely with microfilarial prevalence (r=0.68, P<0.001) and community microfilarial load (r=0.64, P<0.001) than the prevalences of skin depigmentation or other potential rapid indicators. The recommended cut-off value for palpable nodules of 20% or more in males aged >20 years had a sensitivity of 94% and specificity of 50% compared to a cut-off of 40% or more for microfilarial prevalence in all ages. This would mean that in these 32 villages 17 of 18 would have been correctly identified for treatment, and a further 7 at lesser risk would have been targeted for treatment. CONCLUSIONS: Skin snipping and parasitological examination can be replaced by the simpler method of palpating onchocercal nodules to identify communities at serious risk of onchocerciasis. This has important operational benefits for onchocerciasis control programmes.  (+info)

Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico. (7/361)

OBJECTIVE AND METHOD: To compare the utility of an ELISA using 3 recombinant antigens with that of the skin biopsy to estimate incidence of infections in a sentinel cohort of individuals living in an endemic community in southern Mexico during a set of 11 subsequent ivermectin treatments. RESULTS: The apparent community prevalence of infection and microfilarial skin infection before and after 11 treatments with ivermectin plus nodulectomy were 78% and 13%, and 0.68 mf/mg and 0.04 mf/mg, respectively, as measured by skin biopsy. Of a group of 286 individuals participating in all surveys, a sentinel cohort of 42 mf and serologically negative individuals had been followed since 1994. The annual percentage of individuals becoming positive in this cohort was 24% (10/42), 28% (9/33), 0%, and 4.3% (1/23) in 1995, 1996, 1997 and 1998, respectively. Likewise, the incidence in children 5 years and under (n = 13) within this sentinel cohort was 15% (2/13), 18% (2/11), 0% and 11% (1/9), respectively. All individuals became positive to both tests simultaneously, indicating that seroconversion assessed infection incidence as accurately as skin biopsy in the sentinel group. CONCLUSION: Incidence monitoring of a sentinel cohort provides an estimation of the parasite transmission in the community; it is less costly than massive sampling, and a finger prick blood test might be more acceptable in some communities.  (+info)

Distribution of the blinding and nonblinding strains of Onchocerca volvulus in Nigeria. (8/361)

Onchocerciasis remains an important public health problem throughout much of sub-Saharan Africa. Nigeria is the country whose population is most afflicted by onchocerciasis; however, little is known concerning the epidemiology of onchocerciasis in this country. Previous studies demonstrated that onchocerciasis in West Africa exists in two forms, which differ in their clinical and epidemiologic characteristics. This is believed to be due to the existence of 2 strains of Onchocerca volvulus, the causative agent of onchocerciasis. The O-150 polymerase chain reaction has been developed to differentiate these 2 strains, and this method has been used to map the distribution of the blinding and nonblinding strains of O. volvulus in Nigeria. The strain distribution is consistent with what is known concerning the ecology and epidemiology of onchocerciasis in this country. The results also suggest that migration may be affecting the historic distribution of the 2 strains of the parasite in Nigeria.  (+info)

Onchocerciasis is a neglected tropical disease caused by the parasitic worm Onchocerca volvulus. The infection is primarily transmitted through the bites of infected blackflies (Simulium spp.) that breed in fast-flowing rivers and streams. The larvae of the worms mature into adults in nodules under the skin, where females release microfilariae that migrate throughout the body, including the eyes.

Symptoms include severe itching, dermatitis, depigmentation, thickening and scarring of the skin, visual impairment, and blindness. The disease is also known as river blindness due to its association with riverside communities where blackflies breed. Onchocerciasis can lead to significant social and economic consequences for affected individuals and communities. Preventive chemotherapy using mass drug administration of ivermectin is the primary strategy for controlling onchocerciasis in endemic areas.

Onchocerciasis, Ocular is a medical condition that specifically refers to the eye manifestations caused by the parasitic infection, Onchocerca volvulus. Also known as "river blindness," this disease is spread through the bite of infected blackflies.

Ocular onchocerciasis affects various parts of the eye, including the conjunctiva, cornea, iris, and retina. The infection can cause symptoms such as itching, burning, and redness of the eyes. Over time, it may lead to more serious complications like punctate keratitis (small, scattered opacities on the cornea), cataracts, glaucoma, and ultimately, blindness.

The infection is diagnosed through a skin snip or blood test, which can detect the presence of microfilariae (the larval stage of the parasite) or antibodies against the parasite. Treatment typically involves administering oral medications such as ivermectin, which kills the microfilariae and reduces the risk of eye damage. However, it does not kill the adult worms, so multiple doses are often required to control the infection. In some cases, surgery may be necessary to remove advanced ocular lesions.

Onchocerca is a genus of filarial nematode worms that are the causative agents of onchocerciasis, also known as river blindness. The most common species to infect humans is Onchocerca volvulus. These parasites are transmitted through the bite of infected blackflies (Simulium spp.) that breed in fast-flowing rivers and streams.

The adult female worms live in nodules beneath the skin, while the microfilariae, which are released by the females, migrate throughout various tissues, including the eyes, where they can cause inflammation and scarring, potentially leading to blindness if left untreated. The infection is primarily found in Africa, with some foci in Central and South America. Onchocerciasis is considered a neglected tropical disease by the World Health Organization (WHO).

'Onchocerca volvulus' is a species of parasitic roundworm that is the causative agent of human river blindness, also known as onchocerciasis. This disease is named after the fact that the larval forms of the worm are often found in the rivers and streams where the blackfly vectors breed.

The adult female worms measure about 33-50 cm in length and live in nodules beneath the skin, while the much smaller males (about 4 cm long) move between the nodules. The females release microfilariae, which are taken up by blackflies when they bite an infected person. These larvae then develop into infective stages within the blackfly and can be transmitted to another human host during a subsequent blood meal.

The infection leads to various symptoms, including itchy skin, rashes, bumps under the skin (nodules), and in severe cases, visual impairment or blindness due to damage caused to the eyes by the migrating larvae. The disease is prevalent in certain regions of Africa, Latin America, and Yemen. Preventive measures include avoiding blackfly bites, mass drug administration with anti-parasitic drugs, and vector control strategies.

Ivermectin is an anti-parasitic drug that is used to treat a variety of infections caused by parasites such as roundworms, threadworms, and lice. It works by paralyzing and killing the parasites, thereby eliminating the infection. Ivermectin is available in various forms, including tablets, creams, and solutions for topical use, as well as injections for veterinary use.

Ivermectin has been shown to be effective against a wide range of parasitic infections, including onchocerciasis (river blindness), strongyloidiasis, scabies, and lice infestations. It is also being studied as a potential treatment for other conditions, such as COVID-19, although its effectiveness for this use has not been proven.

Ivermectin is generally considered safe when used as directed, but it can cause side effects in some people, including skin rashes, nausea, and diarrhea. It should be used with caution in pregnant women and people with certain medical conditions, such as liver or kidney disease.

Simuliidae is a family of small, robust two-winged flies known as black flies or buffalo gnats. The term "Simuliidae" itself is the taxonomic name for this group of insects. They are called black flies because many species are dark in color, and they are often referred to as gnats or buffalo gnats due to their small size and annoying biting behavior.

Black flies are well-known for their medical significance, as they can transmit several diseases to humans and animals, including onchocerciasis (river blindness), leucocytozoonosis, and various forms of bacterial infections. The female black flies feed on blood from hosts, while males primarily feed on nectar.

These insects are typically found near bodies of water, where their larvae develop in flowing or standing waters with high oxygen levels. They have aquatic habits and undergo a complete metamorphosis during their life cycle, transforming from an egg to larva, then pupa, and finally into an adult fly.

In summary, Simuliidae is the medical term for black flies or buffalo gnats, which are small, robust two-winged flies with a medical significance due to their ability to transmit diseases to humans and animals.

Filaricides are a type of medication used to treat infections caused by filarial worms, which are parasitic roundworms that can infect humans and animals. These medications work by killing or inhibiting the development of the larval stages of the worms, thereby helping to eliminate the infection and prevent further transmission.

Filaricides are often used to treat diseases such as onchocerciasis (river blindness), lymphatic filariasis (elephantiasis), and loiasis (African eye worm). Examples of filaricides include ivermectin, diethylcarbamazine, and albendazole. It is important to note that these medications should only be used under the guidance of a healthcare professional, as they can have serious side effects if not used properly.

Microfilaria is the larval form of certain parasitic roundworms (nematodes) belonging to the family Onchocercidae. These worms include species that cause filariasis, which are diseases transmitted through the bite of infected mosquitoes or blackflies. The microfilariae are found in the blood or tissue fluids of the host and can measure from 200 to 300 microns in length. They have a distinct sheath and a characteristic tail taper, which helps in their identification under a microscope. Different filarial species have specific microfilariae characteristics, such as size, shape, and lifestyle patterns (nocturnal or diurnal periodicity). The presence of microfilariae in the host's blood or tissue fluids is indicative of an ongoing infection with the respective filarial parasite.

Antiparasitic agents are a type of medication used to treat parasitic infections. These agents include a wide range of drugs that work to destroy, inhibit the growth of, or otherwise eliminate parasites from the body. Parasites are organisms that live on or inside a host and derive nutrients at the host's expense.

Antiparasitic agents can be divided into several categories based on the type of parasite they target. Some examples include:

* Antimalarial agents: These drugs are used to treat and prevent malaria, which is caused by a parasite that is transmitted through the bites of infected mosquitoes.
* Antiprotozoal agents: These drugs are used to treat infections caused by protozoa, which are single-celled organisms that can cause diseases such as giardiasis, amoebic dysentery, and sleeping sickness.
* Antihelminthic agents: These drugs are used to treat infections caused by helminths, which are parasitic worms that can infect various organs of the body, including the intestines, lungs, and skin. Examples include roundworms, tapeworms, and flukes.

Antiparasitic agents work in different ways to target parasites. Some disrupt the parasite's metabolism or interfere with its ability to reproduce. Others damage the parasite's membrane or exoskeleton, leading to its death. The specific mechanism of action depends on the type of antiparasitic agent and the parasite it is targeting.

It is important to note that while antiparasitic agents can be effective in treating parasitic infections, they can also have side effects and potential risks. Therefore, it is essential to consult with a healthcare provider before starting any antiparasitic medication to ensure safe and appropriate use.

Parasitic skin diseases are conditions caused by parasites living on or in the skin. These parasites can be insects, mites, or fungi that feed off of the host for their own survival. They can cause a variety of symptoms including itching, rashes, blisters, and lesions on the skin. Examples of parasitic skin diseases include scabies, lice infestations, and ringworm. Treatment typically involves the use of topical or oral medications to kill the parasites and alleviate symptoms.

Mansonelliasis is a parasitic infection caused by the nematode (roundworm) species Mansonella perstans, M. ozzardi, or M. streptocerca. These parasites are transmitted to humans through the bite of infected blackflies or midges. The infection can cause a range of symptoms including fever, headache, pruritus (severe itching), and rash. In some cases, there may be no symptoms at all. Chronic infections can lead to more serious complications such as endocarditis, hepatomegaly (enlarged liver), and splenomegaly (enlarged spleen). However, mansonelliasis is often overlooked or misdiagnosed due to its nonspecific symptoms and the limited availability of diagnostic tests.

Antinematodal agents are a type of medication used to treat infections caused by nematodes, which are also known as roundworms. These agents work by either killing the parasitic worms or preventing them from reproducing. Some examples of antinematodal agents include albendazole, ivermectin, and mebendazole. These medications are used to treat a variety of nematode infections, such as ascariasis, hookworm infection, and strongyloidiasis. It is important to note that the use of antinematodal agents should be under the guidance of a healthcare professional, as they can have side effects and may interact with other medications.

"Western Africa" is a geographical region that consists of several countries located in the western part of the African continent. The United Nations defines Western Africa as the 16 countries of Benin, Burkina Faso, Cape Verde, Gambia, Ghana, Guinea, Guinea-Bissau, Ivory Coast, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, and Togo.

The region is characterized by a diverse range of cultures, languages, and ethnic groups, as well as a variety of landscapes, including coastal areas, savannas, and deserts. Western Africa has a rich history, with many ancient kingdoms and empires having existed in the region, such as the Ghana Empire, Mali Empire, and Songhai Empire.

In medical contexts, "Western Africa" may be used to describe the epidemiology, distribution, or characteristics of various health conditions or diseases that are prevalent in this geographical region. For example, certain infectious diseases such as malaria, HIV/AIDS, and Ebola virus disease are more common in Western Africa than in other parts of the world. Therefore, medical researchers and practitioners may use the term "Western Africa" to refer to the specific health challenges and needs of the populations living in this region.

Diethylcarbamazine (DECT or DEC) is an anti-parasitic medication used to treat infections caused by roundworms, including lymphatic filariasis (elephantiasis) and river blindness (onchocerciasis). It works by killing the parasitic worms, thus helping to prevent the progression of these diseases.

Diethylcarbamazine is typically available as a prescription oral medication in the form of tablets or capsules. The dosage and duration of treatment will depend on the type and severity of the infection being treated. It's important to note that DEC should only be taken under the supervision of a healthcare professional, as it may have side effects and potential drug interactions.

Medical Citation:
"Diethylcarbamazine." National Center for Biotechnology Information. PubChem Compound Database. U.S. National Library of Medicine. . Accessed on April 18, 2023.

Loiasis is a tropical parasitic infection caused by the filarial nematode worm, Loa loa. It is also known as "African eye worm" due to the migration of the adult worm through the subconjunctival tissues of the eye, which is a common symptom. The infection is transmitted through the bite of deerfly or mango fly (Chrysops spp.).

After transmission, the larval form of the parasite migrates through the soft tissues and matures into an adult worm that lives in the subcutaneous tissue. Adult worms can be up to 7 cm long and may cause localized itching or a transient subconjunctival migration, which is painless but alarming to the patient.

Loiasis is usually asymptomatic, but severe symptoms such as Calabar swellings (recurrent angioedema), arthralgia, pruritus, and cardiac or respiratory complications can occur in heavy infections. Diagnosis is made by detecting microfilariae or adult worms in the blood, skin snips, or eye fluid. Treatment typically involves diethylcarbamazine citrate (DEC) therapy, but ivermectin and albendazole can also be used. Preventive measures include avoiding fly bites through the use of protective clothing, insect repellents, and bed nets.

"Loa" is a term used in tropical medicine, specifically in the context of parasitic diseases. It refers to a type of filarial worm that can infect humans and cause a disease known as loiasis (also called "loa loa" or "African eye worm"). The Loa loa parasite is transmitted to humans through the bite of deerfly or mango fly, which acts as a vector.

The adult Loa loa worms typically reside in the subcutaneous tissue of the human host, where they can cause various symptoms such as localized itching, skin rashes, and arthralgias (joint pain). The parasite is also known to migrate through various tissues, including the eye, which can result in the appearance of a visible, moving worm under the conjunctiva. This is how loiasis earned its colloquial name "African eye worm."

Loiasis is primarily found in the rainforest regions of West and Central Africa. While not typically life-threatening on its own, loiasis can complicate the treatment of other filarial diseases such as onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis), due to potential adverse reactions to the medications used to treat these conditions.

Anthelmintics are a type of medication used to treat infections caused by parasitic worms, also known as helminths. These medications work by either stunting the growth of the worms, paralyzing them, or killing them outright, allowing the body to expel the worms through normal bodily functions. Anthelmintics are commonly used to treat infections caused by roundworms, tapeworms, flukeworms, and hookworms. Examples of anthelmintic drugs include albendazole, mebendazole, praziquantel, and ivermectin.

Helminth antigens refer to the proteins or other molecules found on the surface or within helminth parasites that can stimulate an immune response in a host organism. Helminths are large, multicellular parasitic worms that can infect various tissues and organs in humans and animals, causing diseases such as schistosomiasis, lymphatic filariasis, and soil-transmitted helminthiases.

Helminth antigens can be recognized by the host's immune system as foreign invaders, leading to the activation of various immune cells and the production of antibodies. However, many helminths have evolved mechanisms to evade or suppress the host's immune response, allowing them to establish long-term infections.

Studying helminth antigens is important for understanding the immunology of helminth infections and developing new strategies for diagnosis, treatment, and prevention. Some researchers have also explored the potential therapeutic use of helminth antigens or whole helminths as a way to modulate the immune system and treat autoimmune diseases or allergies. However, more research is needed to determine the safety and efficacy of these approaches.

I'm sorry for any confusion, but "Liberia" is not a medical term. It is a country in West Africa, bordering the North Atlantic Ocean, between Côte d'Ivoire and Sierra Leone. Established in 1847, it was the first African republic to proclaim its independence, and is known for its unique history of being settled by freed slaves from the United States. Is there a different term or concept you would like me to define or provide information about?

I'm not aware of any medical condition or term that is specifically associated with or referred to as "Cameroon." Cameroon is a country located in Central Africa, known for its rich biodiversity and cultural diversity. If you have more context about why you are looking for a medical definition of "Cameroon," I may be able to provide a more helpful response.

I'm sorry for any confusion, but "Guinea" is not a medical term. It is a geographical term referring to a region on the west coast of Africa, as well as the country of Equatorial Guinea and its neighboring countries. Additionally, "Guinea" can also refer to a unit of currency in Liberia.

If you have any medical concerns or questions, I would be happy to try to help answer them for you.

Antibodies are proteins produced by the immune system in response to the presence of a foreign substance, known as an antigen. They are capable of recognizing and binding to specific antigens, neutralizing or marking them for destruction by other immune cells.

Helminths are parasitic worms that can infect humans and animals. They include roundworms, tapeworms, and flukes, among others. Helminth infections can cause a range of symptoms, depending on the type of worm and the location of the infection.

Antibodies to helminths are produced by the immune system in response to an infection with one of these parasitic worms. These antibodies can be detected in the blood and serve as evidence of a current or past infection. They may also play a role in protecting against future infections with the same type of worm.

There are several different classes of antibodies, including IgA, IgD, IgE, IgG, and IgM. Antibodies to helminths are typically of the IgE class, which are associated with allergic reactions and the defense against parasites. IgE antibodies can bind to mast cells and basophils, triggering the release of histamine and other inflammatory mediators that help to protect against the worm.

In addition to IgE, other classes of antibodies may also be produced in response to a helminth infection. For example, IgG antibodies may be produced later in the course of the infection and can provide long-term immunity to reinfection. IgA antibodies may also be produced and can help to prevent the attachment and entry of the worm into the body.

Overall, the production of antibodies to helminths is an important part of the immune response to these parasitic worms. However, in some cases, the presence of these antibodies may also be associated with allergic reactions or other immunological disorders.

Eye diseases are a range of conditions that affect the eye or visual system, causing damage to vision and, in some cases, leading to blindness. These diseases can be categorized into various types, including:

1. Refractive errors: These include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, which affect the way light is focused on the retina and can usually be corrected with glasses or contact lenses.
2. Cataracts: A clouding of the lens inside the eye that leads to blurry vision, glare, and decreased contrast sensitivity. Cataract surgery is the most common treatment for this condition.
3. Glaucoma: A group of diseases characterized by increased pressure in the eye, leading to damage to the optic nerve and potential blindness if left untreated. Treatment includes medications, laser therapy, or surgery.
4. Age-related macular degeneration (AMD): A progressive condition that affects the central part of the retina called the macula, causing blurry vision and, in advanced stages, loss of central vision. Treatment may include anti-VEGF injections, laser therapy, or nutritional supplements.
5. Diabetic retinopathy: A complication of diabetes that affects the blood vessels in the retina, leading to bleeding, leakage, and potential blindness if left untreated. Treatment includes laser therapy, anti-VEGF injections, or surgery.
6. Retinal detachment: A separation of the retina from its underlying tissue, which can lead to vision loss if not treated promptly with surgery.
7. Amblyopia (lazy eye): A condition where one eye does not develop normal vision, often due to a misalignment or refractive error in childhood. Treatment includes correcting the underlying problem and encouraging the use of the weaker eye through patching or other methods.
8. Strabismus (crossed eyes): A misalignment of the eyes that can lead to amblyopia if not treated promptly with surgery, glasses, or other methods.
9. Corneal diseases: Conditions that affect the transparent outer layer of the eye, such as keratoconus, Fuchs' dystrophy, and infectious keratitis, which can lead to vision loss if not treated promptly.
10. Uveitis: Inflammation of the middle layer of the eye, which can cause vision loss if not treated promptly with anti-inflammatory medications or surgery.

Chorioretinitis is a medical term that refers to the inflammation of the choroid and the retina, which are both important structures in the eye. The choroid is a layer of blood vessels that supplies oxygen and nutrients to the retina, while the retina is a light-sensitive tissue that converts light into electrical signals that are sent to the brain and interpreted as visual images.

Chorioretinitis can be caused by various infectious and non-infectious conditions, such as bacterial, viral, fungal, or parasitic infections, autoimmune diseases, or cancer. The symptoms of chorioretinitis may include decreased vision, floaters, blurry vision, sensitivity to light, and eye pain. Treatment for chorioretinitis depends on the underlying cause and may include antibiotics, antiviral medications, corticosteroids, or other immunosuppressive therapies. It is important to seek medical attention promptly if you experience any symptoms of chorioretinitis, as timely diagnosis and treatment can help prevent permanent vision loss.

An endemic disease is a type of disease that is regularly found among particular people or in a certain population, and is spread easily from person to person. The rate of infection is consistently high in these populations, but it is relatively stable and does not change dramatically over time. Endemic diseases are contrasted with epidemic diseases, which suddenly increase in incidence and spread rapidly through a large population.

Endemic diseases are often associated with poverty, poor sanitation, and limited access to healthcare. They can also be influenced by environmental factors such as climate, water quality, and exposure to vectors like mosquitoes or ticks. Examples of endemic diseases include malaria in some tropical countries, tuberculosis (TB) in many parts of the world, and HIV/AIDS in certain populations.

Effective prevention and control measures for endemic diseases typically involve improving access to healthcare, promoting good hygiene and sanitation practices, providing vaccinations when available, and implementing vector control strategies. By addressing the underlying social and environmental factors that contribute to the spread of these diseases, it is possible to reduce their impact on affected populations and improve overall health outcomes.

'Insect control' is not a term typically used in medical definitions. However, it generally refers to the methods and practices used to manage or reduce the population of insects that can be harmful or disruptive to human health, food supply, or property. This can include various strategies such as chemical pesticides, biological control agents, habitat modification, and other integrated pest management techniques.

In medical terms, 'vector control' is a more relevant concept, which refers to the specific practices used to reduce or prevent the transmission of infectious diseases by insects and other arthropods that act as disease vectors (such as mosquitoes, ticks, and fleas). Vector control measures may include the use of insecticides, larvicides, biological control agents, environmental management, personal protection methods, and other integrated vector management strategies.

I'm sorry for any confusion, but "Togo" is not a medical term. It is the name of a country in West Africa, known officially as the Togolese Republic. If you have any questions about medical terminology or health-related topics, please don't hesitate to ask!

Neglected Tropical Diseases (NTDs) are a group of infectious diseases that primarily affect people living in poverty, in tropical and subtropical areas. These diseases are called "neglected" because they have been largely ignored by medical research and drug development, as well as by global health agencies and pharmaceutical companies.

The World Health Organization (WHO) has identified 20 diseases as NTDs, including:

1. Buruli ulcer
2. Chagas disease
3. Dengue and chikungunya
4. Dracunculiasis (guinea-worm disease)
5. Echinococcosis
6. Endemic treponematoses
7. Foodborne trematodiases
8. Human African trypanosomiasis (sleeping sickness)
9. Leishmaniasis
10. Leprosy (Hansen's disease)
11. Lymphatic filariasis
12. Onchocerciasis (river blindness)
13. Rabies
14. Schistosomiasis
15. Soil-transmitted helminthiases
16. Snakebite envenoming
17. Taeniasis/Cysticercosis
18. Trachoma
19. Mycetoma, chromoblastomycosis and other deep mycoses
20. Yaws (Endemic treponematoses)

These diseases can lead to severe disfigurement, disability, and even death if left untreated. They affect more than 1 billion people worldwide, mainly in low-income countries in Africa, Asia, and the Americas. NTDs also have significant social and economic impacts, contributing to poverty, stigma, discrimination, and exclusion.

Efforts are underway to raise awareness and increase funding for research, prevention, and treatment of NTDs. The WHO has set targets for controlling or eliminating several NTDs by 2030, including dracunculiasis, lymphatic filariasis, onchocerciasis, trachoma, and human African trypanosomiasis.

I apologize for any confusion, but "Ecuador" is not a medical term or concept. It is the name of a country located in South America, officially known as the "República del Ecuador." If you have any questions related to medicine or health, I would be happy to try and help answer those for you!

I'm sorry for any confusion, but "Sierra Leone" is not a medical term or concept. It is an African country located on the western coast of the continent, known for its rich natural resources and diverse culture. If you have any questions about medical topics or health-related issues, I would be happy to try to help answer them!

The Central African Republic (CAR) is a country located in the central region of Africa. It is not a medical term, but a geographical and political designation for a nation that has its own government, healthcare system, and public health challenges.

The CAR faces significant health issues, including a high burden of infectious diseases such as malaria, HIV/AIDS, tuberculosis, and neglected tropical diseases. Access to healthcare services is limited, particularly in rural areas, and the country has one of the lowest life expectancies in the world. Political instability and conflict have further exacerbated the health challenges in the CAR, leading to displacement, malnutrition, and reduced access to healthcare for many of its citizens.

I'm sorry for any confusion, but "Nigeria" is not a medical term. It is a country located in West Africa, and it is the most populous country in Africa. If you have any questions about medical conditions or terms, I would be happy to help clarify those for you.

Optic atrophy is a medical term that refers to the degeneration and shrinkage (atrophy) of the optic nerve, which transmits visual information from the eye to the brain. This condition can result in various vision abnormalities, including loss of visual acuity, color vision deficiencies, and peripheral vision loss.

Optic atrophy can occur due to a variety of causes, such as:

* Traumatic injuries to the eye or optic nerve
* Glaucoma
* Optic neuritis (inflammation of the optic nerve)
* Ischemic optic neuropathy (reduced blood flow to the optic nerve)
* Compression or swelling of the optic nerve
* Hereditary or congenital conditions affecting the optic nerve
* Toxins and certain medications that can damage the optic nerve.

The diagnosis of optic atrophy typically involves a comprehensive eye examination, including visual acuity testing, refraction assessment, slit-lamp examination, and dilated funduscopic examination to evaluate the health of the optic nerve. In some cases, additional diagnostic tests such as visual field testing, optical coherence tomography (OCT), or magnetic resonance imaging (MRI) may be necessary to confirm the diagnosis and determine the underlying cause.

There is no specific treatment for optic atrophy, but addressing the underlying cause can help prevent further damage to the optic nerve. In some cases, vision rehabilitation may be recommended to help patients adapt to their visual impairment.

Elephantiasis, filarial is a medical condition characterized by the severe swelling of limbs or other parts of the body due to the blockage of lymphatic vessels by parasitic worms. It is caused by infection with threadlike nematode filarial worms, such as Wuchereria bancrofti and Brugia timori. These worms are transmitted to humans through mosquito bites.

The blockage of lymphatic vessels leads to the accumulation of lymph fluid in the affected area, causing progressive swelling, thickening, and hardening of the skin and underlying tissues. In advanced cases, the skin may become rough, nodular, and fissured, resembling the hide of an elephant, hence the name "elephantiasis."

The condition is usually chronic and can cause significant disability and social stigma. While there is no cure for filarial elephantiasis, various treatments are available to alleviate symptoms, prevent transmission, and halt the progression of the disease. These include antibiotics to kill the worms, surgery to remove the lymphatic obstruction, and various supportive measures to manage the swelling and prevent secondary infections.

Blindness is a condition of complete or near-complete vision loss. It can be caused by various factors such as eye diseases, injuries, or birth defects. Total blindness means that a person cannot see anything at all, while near-complete blindness refers to having only light perception or the ability to perceive the direction of light, but not able to discern shapes or forms. Legal blindness is a term used to define a certain level of visual impairment that qualifies an individual for government assistance and benefits; it usually means best corrected visual acuity of 20/200 or worse in the better eye, or a visual field no greater than 20 degrees in diameter.

Insect vectors are insects that transmit disease-causing pathogens (such as viruses, bacteria, parasites) from one host to another. They do this while feeding on the host's blood or tissues. The insects themselves are not infected by the pathogen but act as mechanical carriers that pass it on during their bite. Examples of diseases spread by insect vectors include malaria (transmitted by mosquitoes), Lyme disease (transmitted by ticks), and plague (transmitted by fleas). Proper prevention measures, such as using insect repellent and reducing standing water where mosquitoes breed, can help reduce the risk of contracting these diseases.

Parasite load, in medical terms, refers to the total number or quantity of parasites (such as worms, protozoa, or other infectious agents) present in a host organism's body. It is often used to describe the severity of a parasitic infection and can be an important factor in determining the prognosis and treatment plan for the infected individual.

Parasite load can vary widely depending on the type of parasite, the route of infection, the immune status of the host, and other factors. In some cases, even a small number of parasites may cause significant harm if they are highly virulent or located in critical areas of the body. In other cases, large numbers of parasites may be necessary to produce noticeable symptoms.

Measuring parasite load can be challenging, as it often requires specialized laboratory techniques and equipment. However, accurate assessment of parasite load is important for both research and clinical purposes, as it can help researchers develop more effective treatments and allow healthcare providers to monitor the progression of an infection and evaluate the effectiveness of treatment.

Mebendazole is a medication used to treat various types of worm infections, such as roundworm, whipworm, hookworm, and threadworm. It belongs to a class of drugs called anthelmintics, which work by preventing the worms from absorbing nutrients, leading to their eventual death and elimination from the body.

Mebendazole is available in various forms, including tablets, chewable tablets, and suspensions. It is usually taken as a single dose or for several days, depending on the type and severity of the infection being treated.

It's important to note that mebendazole is not effective against all types of worm infections, so it should only be used under the guidance and supervision of a healthcare professional. Additionally, while taking mebendazole, it's recommended to maintain good hygiene practices, such as washing hands frequently and avoiding contaminated food or water, to prevent reinfection.

Disease eradication is the complete and permanent elimination of a specific disease from all humans or animals worldwide. This is achieved through various methods, including vaccination programs, improved sanitation, and public health measures. The disease is no longer present in any form, and there is no risk of it re-emerging. Smallpox is the only human disease to have been successfully eradicated so far. Efforts are currently underway to eradicate polio, with significant progress made but still ongoing.

I'm sorry for any confusion, but the term "Africa" actually refers to a continent, not a medical condition or concept. Africa is the second-largest continent in the world, consisting of 54 countries and a wide range of diverse ethnic groups, cultures, languages, and landscapes. It is home to a vast array of wildlife, including many species that are not found anywhere else in the world. If you have any questions about Africa's geography, history, or culture, I would be happy to try to help answer them!

Tropical medicine is a branch of medicine that deals with health problems that are prevalent in or unique to tropical and subtropical regions. These regions are typically characterized by hot and humid climates, and often have distinct ecological systems that can contribute to the spread of infectious diseases.

The field of tropical medicine encompasses a wide range of health issues, including:

1. Infectious diseases: Many tropical diseases are caused by infectious agents such as bacteria, viruses, parasites, and fungi. Some of the most common infectious diseases in the tropics include malaria, dengue fever, yellow fever, chikungunya, Zika virus, leishmaniasis, schistosomiasis, and Chagas disease.
2. Neglected tropical diseases (NTDs): A group of chronic infectious diseases that primarily affect poor and marginalized populations in the tropics. NTDs include diseases such as human African trypanosomiasis (sleeping sickness), leprosy, Buruli ulcer, and dracunculiasis (guinea worm disease).
3. Zoonotic diseases: Diseases that are transmitted between animals and humans, often through insect vectors or contaminated food and water. Examples of zoonotic diseases in the tropics include rabies, leptospirosis, and Rift Valley fever.
4. Environmental health issues: The tropical environment can pose unique health challenges, such as exposure to toxic chemicals, heat stress, and poor air quality. Tropical medicine also addresses these environmental health issues.
5. Travel medicine: As global travel increases, there is a growing need for medical professionals who are knowledgeable about the health risks associated with traveling to tropical destinations. Tropical medicine physicians often provide pre-travel consultations and post-travel evaluations for international travelers.

Overall, tropical medicine is an essential field that addresses the unique health challenges faced by populations living in or traveling to tropical and subtropical regions.

I'm sorry for any confusion, but "Mali" is not a medical term or condition in English. Mali is the name of a country located in West Africa, and its capital city is Bamako. If you have any questions about Mali or anything else, please let me know!

I'm sorry for any confusion, but "Gift Giving" is not a medical term or concept. It refers to the social practice of giving gifts to others, often as a sign of affection, celebration, or appreciation. If you have any questions related to medicine or health, I would be happy to try and help answer those for you!

Filariasis is a parasitic disease caused by infection with roundworms of the Filarioidea type. The infection is spread through the bite of infected mosquitoes and can lead to various symptoms depending on the type of filarial worm, including lymphatic dysfunction (elephantiasis), eye damage (onchocerciasis or river blindness), and tropical pulmonary eosinophilia. The disease is prevalent in tropical areas with poor sanitation and lack of access to clean water. Preventive measures include wearing protective clothing, using insect repellents, and sleeping under mosquito nets. Treatment typically involves the use of antiparasitic drugs such as diethylcarbamazine or ivermectin.

Wolbachia is a genus of intracellular bacteria that naturally infects a wide variety of arthropods (insects, spiders, mites) and filarial nematodes (roundworms). These bacteria are transmitted vertically from mother to offspring, often through the cytoplasm of eggs. Wolbachia can manipulate the reproductive biology of their hosts in various ways, such as feminization, parthenogenesis, male killing, and cytoplasmic incompatibility, which favor the spread and maintenance of the bacteria within host populations. The interactions between Wolbachia and their hosts have implications for insect pest management, disease transmission, and evolutionary biology.

I'm sorry for any confusion, but "Ghana" is not a medical term. It is the name of a country located in West Africa, known officially as the Republic of Ghana. If you have any questions about medical terms or conditions, I would be happy to help with those!

Filarioidea is a superfamily of parasitic nematode (roundworm) worms, many of which are important pathogens in humans and animals. They are transmitted to their hosts through the bite of insect vectors, such as mosquitoes or flies. The filarioid worms can cause a range of diseases known as filariases. Some examples include Wuchereria bancrofti, Brugia malayi, and Onchocerca volvulus, which cause lymphatic filariasis (elephantiasis) and river blindness, respectively. The adult worms live in the lymphatic system or subcutaneous tissues of their hosts, where they produce microfilariae, the infective stage for the insect vector.

The medical definition of Filarioidea is: A superfamily of parasitic nematode worms that includes several important human pathogens and causes various filariases. The adult worms live in the lymphatic system or subcutaneous tissues, while the microfilariae are taken up by insect vectors during a blood meal and develop into infective larvae inside the vector. These larvae are then transmitted to a new host through the bite of the infected vector.

Helminth DNA refers to the genetic material found in parasitic worms that belong to the phylum Platyhelminthes (flatworms) and Nematoda (roundworms). These parasites can infect various organs and tissues of humans and animals, causing a range of diseases.

Helminths have complex life cycles involving multiple developmental stages and hosts. The study of their DNA has provided valuable insights into their evolutionary history, genetic diversity, and mechanisms of pathogenesis. It has also facilitated the development of molecular diagnostic tools for identifying and monitoring helminth infections.

Understanding the genetic makeup of these parasites is crucial for developing effective control strategies, including drug discovery, vaccine development, and disease management.

Dipetalonema is a genus of parasitic nematodes (roundworms) that can infect various mammals, including humans. Two species within this genus, Dipetalonema perstans and Dipetalonema streptocerca, are known to cause human filariasis, a group of tropical diseases characterized by the presence of parasitic worms in the lymphatic system.

Dipetalonema perstans is also known as "persistent strongyloides" and can cause a condition called "tropical pulmonary eosinophilia." This species has a complex life cycle involving mosquitoes as intermediate hosts. The adult worms reside in the abdominal cavity of the human host, where they produce microfilariae that circulate in the bloodstream. When an infected mosquito takes a blood meal, it ingests the microfilariae, which then develop into infective larvae inside the mosquito. Upon subsequent bites by the mosquito, these infective larvae enter the human host and migrate to the abdominal cavity, where they mature into adults and continue the life cycle.

Dipetalonema streptocerca is primarily found in West Africa and causes a condition known as "cutaneous filariasis" or "subcutaneous filariasis." This species has a similar life cycle to D. perstans, but it involves biting midges (culicoides) instead of mosquitoes as intermediate hosts. The adult worms reside in the subcutaneous tissue, where they produce microfilariae that circulate in the skin. Infective larvae develop inside the biting midge and are transmitted to humans during blood feeding.

The symptoms of Dipetalonema infections can vary widely depending on the species and the severity of the infection. Some people may not experience any symptoms, while others may have fever, cough, wheezing, skin rashes, or lymphatic swelling (lymphedema). Treatment typically involves administration of anti-parasitic drugs such as diethylcarbamazine or ivermectin.

Diptera is an order of insects that includes flies, mosquitoes, and gnats. The name "Diptera" comes from the Greek words "di," meaning two, and "pteron," meaning wing. This refers to the fact that all members of this order have a single pair of functional wings for flying, while the other pair is reduced to small knob-like structures called halteres, which help with balance and maneuverability during flight.

Some common examples of Diptera include houseflies, fruit flies, horseflies, tsetse flies, and midges. Many species in this order are important pollinators, while others can be significant pests or disease vectors. The study of Diptera is called dipterology.

Schistosomiasis, also known as bilharzia or snail fever, is a parasitic infection caused by several species of the trematode flatworm Schistosoma. The infection occurs when people come into contact with freshwater contaminated with the parasite's larvae, which are released by infected freshwater snails.

The larvae penetrate the skin, enter the bloodstream, and mature into adult worms in the blood vessels of the urinary tract or intestines. The female worms lay eggs, which can cause inflammation and scarring in various organs, including the liver, lungs, and brain.

Symptoms of schistosomiasis may include fever, chills, cough, muscle aches, and diarrhea. In chronic cases, the infection can lead to serious complications such as kidney damage, bladder cancer, and seizures. Schistosomiasis is prevalent in tropical and subtropical regions with poor sanitation and lack of access to safe drinking water. It is preventable through improved water supply, sanitation, and snail control measures. Treatment typically involves the use of a medication called praziquantel, which kills the adult worms.

Parasitic diseases are infections or illnesses caused by parasites, which are organisms that live and feed on host organisms, often causing harm. Parasites can be protozoans (single-celled organisms), helminths (worms), or ectoparasites (ticks, mites, fleas). These diseases can affect various body systems and cause a range of symptoms, depending on the type of parasite and the location of infection. They are typically spread through contaminated food or water, insect vectors, or direct contact with an infected host or contaminated environment. Examples of parasitic diseases include malaria, giardiasis, toxoplasmosis, ascariasis, and leishmaniasis.

Mansonella is a genus of filarial nematodes (roundworms) that are transmitted to humans through the bites of infected blackflies or mosquitoes. There are several species within this genus, including M. perstans, M. ozzardi, and M. streptocerca, which can cause different clinical manifestations in humans.

Mansonella perstans is the most widespread species, found mainly in Africa and some parts of Central and South America. The adult worms reside in the abdominal cavity and the thoracic cavity, where they release microfilariae into the bloodstream. This species does not usually cause severe symptoms, but chronic infection can lead to general malaise, fatigue, and peripheral eosinophilia (high levels of eosinophils in the blood).

Mansonella ozzardi is found primarily in Central and South America, and its vectors are mosquitoes. The adult worms reside in the body cavities, subcutaneous tissues, and the peritoneal cavity. Infection with M. ozzardi can cause dermatological manifestations such as pruritus (itching), papular rash, and calcified nodules under the skin.

Mansonella streptocerca is transmitted through bites of infected midges in West and Central Africa. The adult worms live in the subcutaneous tissues, particularly around the head and neck regions, leading to pruritus, papular rash, and lymphadenopathy (swollen lymph nodes).

Diagnosis of Mansonella infections is typically made through the detection of microfilariae in blood samples, often obtained during nighttime due to the nocturnal periodicity of some species. Treatment usually involves the administration of antiparasitic drugs such as ivermectin or diethylcarbamazine.

Communicable disease control is a branch of public health that focuses on preventing and controlling the spread of infectious diseases within a population. The goal is to reduce the incidence and prevalence of communicable diseases through various strategies, such as:

1. Surveillance: Monitoring and tracking the occurrence of communicable diseases in a population to identify trends, outbreaks, and high-risk areas.
2. Prevention: Implementing measures to prevent the transmission of infectious agents, such as vaccination programs, education campaigns, and environmental interventions (e.g., water treatment, food safety).
3. Case management: Identifying, diagnosing, and treating cases of communicable diseases to reduce their duration and severity, as well as to prevent further spread.
4. Contact tracing: Identifying and monitoring individuals who have been in close contact with infected persons to detect and prevent secondary cases.
5. Outbreak response: Coordinating a rapid and effective response to disease outbreaks, including the implementation of control measures, communication with affected communities, and evaluation of interventions.
6. Collaboration: Working closely with healthcare providers, laboratories, policymakers, and other stakeholders to ensure a coordinated and comprehensive approach to communicable disease control.
7. Research: Conducting research to better understand the epidemiology, transmission dynamics, and prevention strategies for communicable diseases.

Effective communicable disease control requires a multidisciplinary approach that combines expertise in medicine, epidemiology, microbiology, public health, social sciences, and healthcare management.

I'm sorry for any confusion, but "Guatemala" is not a medical term or concept. It is the name of a country located in Central America. If you have any questions related to medical terminology or health-related topics, I would be happy to help with those!

Niridazole is an anti-parasitic medication that was previously used to treat infections caused by parasites such as schistosomiasis (also known as bilharzia or snail fever) and loiasis (also known as African eye worm). It works by inhibiting the metabolism of the parasites, leading to their death. However, due to its side effects, including neurotoxicity and potential for causing optic neuritis, it is no longer commonly used in clinical practice.

The "Americas" is a term used to refer to the combined landmasses of North America and South America, which are separated by the Isthmus of Panama. The Americas also include numerous islands in the Caribbean Sea, Atlantic Ocean, and Pacific Ocean. This region is home to a diverse range of cultures, ecosystems, and historical sites. It is named after the Italian explorer Amerigo Vespucci, who was one of the first Europeans to explore and map parts of South America in the late 15th century.

I'm sorry for any confusion, but "Uganda" is not a medical term or concept. It is the name of a country located in East Africa, known officially as the Republic of Uganda. If you have any questions about medical terms or concepts, I would be happy to help with those!

Necatoriasis is a parasitic infection caused by the nematode (roundworm) Necator americanus, also known as the "New World hookworm." This condition is primarily found in areas with warm, moist climates and poor sanitation. The infection typically occurs when the larvae of the parasite penetrate the skin, usually through bare feet that come into contact with contaminated soil.

Once inside the human body, the larvae migrate to the lungs, where they mature and are coughed up and swallowed. They then reside in the small intestine, where they feed on blood and cause symptoms such as abdominal pain, diarrhea, anemia, and growth retardation in children. Necatoriasis is usually treated with anthelmintic medications like albendazole or mebendazole. Preventive measures include wearing shoes in areas where the parasite is common and improving sanitation to reduce the spread of contaminated soil.

"Onchocerciasis (river blindness)". www.who.int. Retrieved 2022-11-21. "Onchocerciasis (river blindness)". www.who.int. ... No vaccine to prevent onchocerciasis infection in humans is available. A vaccine to prevent onchocerciasis infection for cattle ... As of 2017, about 99% of onchocerciasis cases occurred in Africa. Onchocerciasis is currently relatively common in 31 African ... In September 2015, the Onchocerciasis Elimination Program for the Americas announced that onchocerciasis only remained in a ...
For river blindness (onchocerciasis) and lymphatic filariasis, ivermectin is typically given as part of mass drug ... "Onchocerciasis". World Health Organization. June 14, 2019. Archived from the original on April 11, 2020. Retrieved January 11, ... Crump A, Morel CM, Omura S (July 2012). "The onchocerciasis chronicle: from the beginning to the end?". Trends in Parasitology ... The Carter Center River Blindness (Onchocerciasis) Control Program "Ivermectin Topical". MedlinePlus. Portal: Medicine (CS1: ...
"Onchocerciasis". Merriam-Webster Dictionary. Retrieved 2016-01-21. "Onchocerciasis". Lexico UK English Dictionary. Oxford ... such as ivermectin for onchocerciasis (river blindness); showing how packaging can improve use of artemesinin-combination ...
Onchocerciasis was eliminated from Colombia in 2013, Ecuador in 2014, Mexico in 2015, and Guatemala in 2016 due to control ... O. volvulus causes onchocerciasis, which causes severe itching. Long-term infection can cause keratitis, an inflammation of the ... "Progress towards eliminiating onchocerciasis in the WHO region of the Americas: Verification of elimination of transmission in ... Burnham, G. (1998). "Onchocerciasis". Lancet. 351 (9112): 1341-1346. doi:10.1016/S0140-6736(97)12450-3. ISSN 0140-6736. PMID ...
"Onchocerciasis". Archived from the original on 16 March 2014. Retrieved 16 March 2014. "Onchocerciasis". Archived from the ... Onchocerciasis is also known as river blindness. There are 20.9 million people infected, and prevalence is higher in rural ... Merck has helped The African Programme for the Control of Onchocerciasis (APOC) and Oncho Elimination Programme for the ... These seven are among a larger list of thirteen major NTDs: onchocerciasis, leishmaniasis, Chagas disease, leprosy, human ...
"Onchocerciasis". Sabin. 28 April 2017. Archived from the original on 12 July 2017. Retrieved 11 September 2017. Hotez, Peter J ... "The Partners". The Onchocerciasis Vaccine for Africa Initiative. Archived from the original on 14 February 2017. Retrieved 11 ... "The Onchocerciasis Vaccine for Africa (TOVA) - A global initiative to advance river blindness vaccine". Edinburgh Infectious ... and Onchocerciasis (Ov-103, Ov-RAL-2). In 2006, Sabin co-founded the Global Network for Neglected Tropical Diseases in order " ...
Onchocerciasis ("river blindness"), a common cause of blindness, is also endemic to parts of the region. More than 99% of ... "WHO , Onchocerciasis". Who.int. Archived from the original on 16 March 2014. Retrieved 29 September 2015. "WHO , Maternal ... In response, the African Programme for Onchocerciasis Control (APOC) was launched in 1995 with the aim of controlling the ...
"Fact Sheets: Onchocerciasis". World Health Organization. 23 November 2018. Retrieved 6 May 2019. "Onchocerciasis - "River ... the African Programme for Onchocerciasis Control reports a reduction in the prevalence of onchocerciasis in the countries under ... Onchocerciasis (river blindness) is the world's second leading cause of infectious blindness. It is caused by the nematode ... "African Programme for Onchocerciasis Control - report of the sixth meeting of national task forces, October 2009". WHO Weekly ...
Onchocerciasis ("river blindness"), a common cause of blindness, is also endemic to parts of the region. More than 99% of ... "Onchocerciasis (river blindness)". World Health Organization. Archived from the original on 22 April 2018. Retrieved 10 May ... In response, the African Programme for Onchocerciasis Control (APOC) was launched in 1995 with the aim of controlling the ...
"Onchocerciasis (river blindness)". www.who.int. Retrieved 2023-06-16. Sanjit Bagchi (April 26, 2006). "Study raises hopes of ...
Ovuga E, Kipp W, Mungherera M, Kasoro S (1992). "Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in ... Marin B, Boussinesq M, Druet-Cabanac M, Kamgno J, Bouteille B, Preux PM (2006). "Onchocerciasis-related epilepsy? Prospects at ... "Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy". Neuroepidemiology. 23 (3 ...
Intradermal onchocerciasis of cattle results in losses in leather due to Onchocerca dermata, O. ochengi, and O. dukei. O. ... Onchocerca volvulus manifests itself in the eyes, causing "river blindness" (onchocerciasis), one of the leading causes of ... This creates difficulties for routine mass treatment because people with onchocerciasis in particular react badly to treatment ... "Lymphatic filariasis and onchocerciasis". Lancet. 376 (9747): 1175-85. doi:10.1016/s0140-6736(10)60586-7. PMID 20739055. S2CID ...
National Onchocerciasis Control Programme (NOCP) Nigeria, Consultant on Rapid Epidemiological Mapping of Onchocerciasis (REMO) ... "Onchocerciasis and its Socioeconomic Effects" (PDF). Dozie, I. N. S.; Okeke, C. N.; Unaeze, N. C. (1994-09-01). "A thermostable ... Onchocerciasis and epilepsy in parts of the Imo River Basin, Nigeria: A preliminary report. Public Health, 120 (5): 448-450 ( ... Onchocerciasis in Imo State, Nigeria. 2. The prevalence, intensity and distribution in the Upper Imo River Basin. International ...
JHubert H Fam (2019-11-21). "Onchocerciasis (African River Blindness)". American Academy of Ophthalmology. Schonberg, Stacy; ... Ocular trauma Corneal ulceration Xerophthalmia, caused by Vitamin A deficiency Trachoma Onchocerciasis Mucous membrane ...
To find onchocerciasis patients, Ridley left the coastal city and travelled overland with Captain John Holden to north west ... Most (90%) had onchocerciasis; ten percent of them were blind. Conditions were primitive and Ridley recorded his observations ... His monograph 'Ocular Onchocerciasis', published in 1945 in a supplement of the British Journal of Ophthalmology, was a ... "Ocular Onchocerciasis Including an Investigation in the Gold Coast". British Journal of Ophthalmology. 29 (Suppl): 3-58. 1945. ...
The Onchocerciasis life cycle involves transmission via a black fly vector. In this life-cycle, the life expectancy of the ... For instance, time-series data for Onchocerciasis infection demonstrates that 10 years of vector control lead to reduced ... Basanez, M.G. (1996). "Density-dependent processes in the onchocerciasis: relationship between microfilarial intake and ... Plaisier, A.P. (1996). Modelling Onchocerciasis Transmission and Control. Rotterdam: Erasmus University. ISBN 90-72245-68-7. ...
Way: Raga River (200829470). Onchocerciasis control programme, p. 2. Onchocerciasis control programme (PDF), World Health ... The river is home to Onchocerca volvulus, the parasite that causes Onchocerciasis, which causes blindness and is a serious ...
Paganelli, R.; Ngu, J. L.; Levinsky, R. J. (March 31, 1980). "Circulating immune complexes in onchocerciasis". Clinical and ...
... his research focus was onchocerciasis. In 1991, he returned to the LSTM as its Director, a position he held until 2000. His ...
Hotez, Peter J. (June 16, 2007). "Control of onchocerciasis-the next generation". The Lancet. 369 (9578): 1979-1980. doi: ...
"African Programme for Onchocerciasis Control (APOC)". World Health Organization. Archived from the original on 6 August 2008. ...
It is estimated that her CDTI strategy has resulted in the treatment of over 112.4 million people for onchocerciasis, 11 ... She is best known for her research on onchocerciasis and her consequent contributions to the World Health Organization (WHO). ... It was during this period in the late 1970s that she began studying onchocerciasis (river blindness) after encountering the ... The results from this replication resulted in the founding of the African Programme for Onchocerciasis Control (APOC) in 1995. ...
Onchocerciasis is a neglected tropical disease. The primary strategy to control onchocerciasis is to interrupt the life cycle ... manufactures the drug and provides it free worldwide for the treatment of onchocerciasis. Onchocerciasis is a parasitic disease ... CDTI has been adopted worldwide as the primary method for mass distribution of Mectizan to control onchocerciasis. UFAR works ... It also requires education to address long-held myths about the causes of onchocerciasis. This educational process begins with ...
Since 1996, the center has been a leader in the fight against onchocerciasis, commonly known as river blindness - a parasitic ... as well as controlling and treating onchocerciasis, trachoma, lymphatic filariasis, and malaria through awareness campaigns. In ... ". "Onchocerciasis Elimination Program for the Americas (OEPA)". The Carter Center. Retrieved 2023-10-03. "Pan American Health ...
Consideration of national onchocerciasis control plans and project proposals (CDTI, vector elimination and headquarters support ... 7. African Programme for Onchocerciasis Control, 2004. "Congo (Dem. Rep.): largest cities and towns and statistics of their ...
ISBN 978-3-11-081351-7. "Managing a national onchocerciasis control programme" (PDF). Retrieved 21 February 2020. v t e (CS1 ...
Onchocerciasis (river blindness) is not a problem in India.[citation needed] Onchocerciasis has been found in India in an ... Barua, P; Sharma, A; Hazarika, NK; Barua, N; Bhuyan, S; Alam, ST (November 2011). "A rare case of ocular onchocerciasis in ...
M.K. Zarfoss et al.: Canine ocular onchocerciasis in the United States: two new cases and a review of the literature. In: Vet. ... The causative agent of canine onchocerciasis is Onchocerca lupi. The disease occurs in North America and some European ...
... is a cutaneous condition, a localized type of onchocerciasis.: 440 This is mostly seen in patients with the disease from ...
He also studied onchocerciasis vectors and helped in monitoring and examining the effectiveness of control measures. Along with ... Bump, Jesse B. (2014-10-09). "The Crosskey-Davies Experiment and Onchocerciasis Control in West Africa". PLOS Neglected ...
Frequently asked questions about Onchocerciasis, also known as River Blindness. ... What is onchocerciasis?. Onchocerciasis is an infection caused by the parasitic worm Onchocerca volvulus, spread by the bite of ... What should I do if I think I may have onchocerciasis?. If you think you might have onchocerciasis, see your health care ... In what parts of the world am I more likely to get onchocerciasis?. Onchocerciasis is locally transmitted in 31 countries of ...
"Onchocerciasis (river blindness)". www.who.int. Retrieved 2022-11-21. "Onchocerciasis (river blindness)". www.who.int. ... No vaccine to prevent onchocerciasis infection in humans is available. A vaccine to prevent onchocerciasis infection for cattle ... As of 2017, about 99% of onchocerciasis cases occurred in Africa. Onchocerciasis is currently relatively common in 31 African ... In September 2015, the Onchocerciasis Elimination Program for the Americas announced that onchocerciasis only remained in a ...
Humans acquire onchocerciasis through the bite of Simulium blackflies. ... Onchocerciasis is an infection caused by the nematode Onchocerca volvulus. ... Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser. ... Onchocerciasis is an infection caused by the nematode Onchocerca volvulus. Humans acquire onchocerciasis through the bite of ...
Onchocerciasis-guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis-criteria and ... Onchocerciasis / River Blindness. CDC Yellow Book 2024. Travel-Associated Infections & Diseases Author(s): Paul Cantey, Sharon ... CDC website: Onchocerciasis (also known as River Blindness). The following authors contributed to the previous version of this ... Onchocerciasis is endemic to much of sub-Saharan Africa. Small endemic foci also are present in the Arabian Peninsula (Yemen) ...
talk contribs‎ m 19,365 bytes +94‎ Protected Onchocerciasis: copyedited [edit=sysop:move=sysop] ...
... onchocerciasis - Raising our voices to improve health around the world. ... Tags Guinea worm disease, London Declaration, lymphatic filariasis, NTD Summit, onchocerciasis, Tanzania, trachoma ...
Onchocerciasis. In this section:. *Status of endemicity of onchocerciasis. *Estimated number of individuals in the country ...
... Goto Sponge Distinct Permalink An Entity of Type : foaf:Concept, within Data Space : www.openlinksw.com ... Onchocerciasis is the worlds second-leading infectious cause of blindness. The vast majority of infections occur in sub- ... Onchocerciasis (pronounced /ˈɒŋkɵsɜrˈsaɪ.əsɨs/ or /ˈɒŋkɵsɜrˈkaɪ.əsɨs/), also known as river blindness and Robles Disease, is a ... An estimated 18 million people suffer from onchocerciasis, with approximately 270,000 cases of blindness related to the ...
What is onchocerciasis?. Unlike in Africa, Yemen has no records of eye complications or blindness due to onchocerciasis. The ... Onchocerciasis is targeted for elimination defined as verified interruption of transmission by 2030 in at least 12 countries ... Onchocerciasis causes sever itching, skin damage ("onchodermatitis" or "reactive onchodermatitis") and eye lesions eventually ... In the Eastern Mediterranean Region, onchocerciasis is transmitted in Yemen and Sudan with an estimated one million people ...
Learn about the veterinary topic of Onchocerciasis in Animals. Find specific details on this topic and related topics from the ... Onchocerciasis in Animals By Richard W. Gerhold, Jr. , DVM, PhD, Department of Biomedical and Diagnostic Sciences, College of ... Diagnosis of Onchocerciasis in Animals *. Clinical evaluation in combination with histology can be used to identify parasites ... Onchocerciasis is a dermatitis in equines and ruminants caused by microfilariae produced by adult Onchocerca. The parasites are ...
Onchocerciasis (River Blindness) is caused by a filaria worm that gets into a persons body as a result of a black flys bite. ... The National Onchocerciasis Control program was established in 1992 to undertake programs aimed at controlling and eliminating ... National Strategies for the Control and Elimination of Onchocerciasis. 1. Mass Drug Administration with Ivermectin and vector ... PROGRAM FUTURE OUTLOOK FOR ONCHOCERCIASIS ELIMINATION: Uganda has adopted a shift from control to elimination in 2007 and there ...
The finding implied that there is no onchocerciasis in the area and, therefore, there is no need for interventions. Black fly ... Therefore, this study was conducted to map onchocerciasis transmission in those zones. About 19 villages were selected based on ... Onchocerciasis is mainly found in western part of Ethiopia and there is no evidence of transmission in the east ward. However, ... WHO, "Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control," World Health Organization ...
"Onchocerciasis" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Onchocerciasis" by people in this website by year, and whether ... Below are the most recent publications written about "Onchocerciasis" by people in Profiles. ... "Onchocerciasis" was a major or minor topic of these publications. To see the data from this visualization as text, click here. ...
... which established the objective of eliminating onchocerciasis by 2012. ... CD48/R12 - Towards the Elimination of Onchocerciasis (River Blindness) in the Region of the Americas ... CD48/R12 - Towards the Elimination of Onchocerciasis (River Blindness) in the Region of the Americas ... which established the objective of eliminating onchocerciasis by 2012. ...
Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection ... In summary, the dominant risk factor for children to become infected is maternal onchocerciasis, and also age-associated ... Longitudinal follow up of children showed that during vector control activities by the Onchocerciasis Control Programme (OCP) ...
Abstract on The African Programme for Onchocerciasis Control (APOC), which was launched in 1995 for the ultimate purpose of ... eliminating human onchocerciasis from the African countries in which the disease was endemic. Amazigo, Annals of Tropical ...
The One Health Initiative is a movement to forge co-equal, all inclusive collaborations between physicians, osteopathic physicians, veterinarians, dentists, nurses, and other scientific-health and environmentally related disciplines.
Read Breaking News, opinion, analysis on african program for onchocerciasis control updated and published at Down To Earth. ... Get latest news on african program for onchocerciasis control. ... 1 Search Results for african program for onchocerciasis control ...
1995) Onchocerciasis and its control. Report of a WHO Expert Committee on onchocerciasis control. (WHO, Geneva) , WHO Technical ... The six cases of blindness found in areas hypoendemic for onchocerciasis were due to onchocerciasis in two of six (33.3%), and ... The prevalence of bilateral blindness from onchocerciasis alone was 98 of 6086 (1.6%). Onchocerciasis was associated with all ... However, onchocerciasis leads to a reduced life expectancy in heavily infected areas.12 It may be assumed that the proportion ...
The Mectizan Donation Program congratulates Yemen for a successful April 2018 mass drug administration (MDA) for onchocerciasis ...
The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Share This * ... Despite high rates, less than half of people participating in the study took ivermectin (a control strategy for onchocerciasis ... Urgent action is needed to prevent children from developing onchocerciasis-associated epilepsy by strengthening the local ... onchocerciasis-elimination programme.. Details. Journal Title. Pathogens. Publisher. MDPI. Published. 24/03/2022. Organisation ...
Onchocerciasis in the state of Texas is extremely rare and is poorly documented, making this a unique case seen at TVMDL. ... Rare case of ocular onchocerciasis in a dog from south Texas. Erin Edwards, DVM, MS, DACVP and Mindy Borst, LVT ... Rare case of ocular onchocerciasis in a dog from south Texas. January 25, 2023. by Mallory Pfeifer ... In the United States, most cases of documented canine onchocerciasis have been from the southwestern United States, primarily ...
... infects approximately 13 to 20 million persons, rendering 1 to 5% of them blind. ... ONCHOCERCIASIS. EPIDEMIOLOGY. Onchocerciasis infects approximately 13 to 20 million persons, rendering 1 to 5% of them blind. ... Onchocerciasis infects approximately 13 to 20 million persons, rendering 1 to 5% of them blind. ...
Onchocerciasis Onchocerciasis is a chronic parasitic infection that primarily affects the skin and eyes, leading to severe ... Eye Disease and Blindness: One of the most severe effects of Onchocerciasis is eye disease, which can lead to visual impairment ... Causative Agent and Transmission: Onchocerciasis is caused by the parasitic worm Onchocerca volvulus. It is transmitted to ... Prevention and Control: Efforts to control Onchocerciasis focus on eliminating the blackfly vector through insecticide spraying ...
Differentiating Onchocerciasis from other Diseases. Epidemiology and Demographics. Risk Factors. Natural History, Complications ... "Lymphatic filariasis and onchocerciasis". Lancet. 376 (9747): 1175-85. doi:10.1016/S0140-6736(10)60586-7. PMID 20739055.. CS1 ... Retrieved from "https://www.wikidoc.org/index.php?title=Onchocerciasis&oldid=1357975" ...
You searched for : Onchocerciasis Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination ... 500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis... Oct 22 ...
Onchocerciasis, more commonly known as river blindness, is a parasitic disease of the skin and eyes. ... Onchocerciasis, more commonly known as river blindness, is a parasitic disease of the skin and eyes. It is caused by the bite ... Onchocerciasis Elimination Program for the Americas (OEPA) and African Programm…. Neglected Tropical Disease NGDO Network: ... Recently, large-scale treatment strategies, such as the African Programme for Onchocerciasis (APOC; ended December 2015) and ...
Information on Onchocerciasis, which may include symptoms, causes, inheritance, treatments, orphan drugs, associated orgs, and ... Dont fight Onchocerciasis alone.. Find your community on the free RareGuru App. Connect with other caregivers and patients ... Onchocerciasis is a rare tropical parasitic disease transmitted by a black fly. Infection by the parasite can cause eye and ... Dont fight Onchocerciasis alone!. Find your community on the free RareGuru App. Connect with caregivers and patients with ...
Shedding Light on NTDs: Onchocerciasis / River Blindness. June 25, 2018. Lauren Goodwin ... Colombia has just been confirmed as the first nation to eliminate the neglected tropical disease onchocerciasis, more commonly ...
  • Onchocerciasis, also known as river blindness, is a disease caused by infection with the parasitic worm Onchocerca volvulus. (wikipedia.org)
  • Onchocerciasis (pronounced /ˈɒŋkɵsɜrˈsaɪ.əsɨs/ or /ˈɒŋkɵsɜrˈkaɪ.əsɨs/), also known as river blindness and Robles' Disease, is a parasitic disease caused by infection with the nematode Onchocerca volvulus. (openlinksw.com)
  • Onchocerciasis - or "river blindness" - is a parasitic disease caused by the filarial worm Onchocerca volvulus transmitted by repeated bites of infected blackflies ( Simulium spp. (who.int)
  • Some of the key partners included River Blindness foundation (Carter Center), GIZ, African Program for Onchocerciasis Control (APOC), Sightsavers and Envision/RTI. (health.go.ug)
  • Onchocerciasis (River Blindness) is caused by a filaria worm that gets into a persons' body as a result of a black fly's bite. (health.go.ug)
  • Onchocerciasis (river blindness) is a neglected tropical parasitic disease (NTD) caused by a filarial nematode worm called Onchocerca volvulus encapsulated in nodules under the skin. (hindawi.com)
  • Enough Mectizan is provided by the Mectizan Donation Program to treat more than 36,000 people for river blindness resulting in an impressive 88% treatment coverage for onchocerciasis! (iapb.org)
  • Onchocerciasis, more commonly known as river blindness, is a parasitic disease of the skin and eyes. (infontd.org)
  • ended December 2015) and the Onchocerciasis Elimination Program of the Americas (OEPA), have resulted in interrupted transmission in 11 of 13 endemic areas in America, higher therapeutic coverage and the successful elimination of river blindness in Colombia (2013), Ecuador (2014), and Mexico (2015). (infontd.org)
  • The Conference, which was organized by The Carter Center and the World Health Organization, with funding from the Bill & Melinda Gates Foundation, addressed the question: "Is onchocerciasis (River Blindness) eradicable with current knowledge and tools? (qxmd.com)
  • Human onchocerciasis, commonly known as River Blindness is endemic in 34 countries, despite some control efforts now spanning into their fourth decade. (imperial.ac.uk)
  • Onchocerciasis is spread though the bite of female blackflies that breed in swiftly flowing streams (hence, the term river blindness). (msdmanuals.com)
  • Onchocerciasis, commonly known as river blindness, is caused by a parasitic worm transmitted to humans through the bite of the blackfly. (outbreaknewstoday.com)
  • Like lymphatic filariasis, Onchocerciasis has significant social and economic impacts, especially in affected rural communities. (who.int)
  • Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis. (medicircle.in)
  • With the World Health Organization (WHO) identifying some vector borne diseases (VBDs) as potentially eliminable / eradicable (e.g., onchocerciasis, lymphatic filariasis, schistosomiasis), it is timely to evaluate whether current transmission dynamics and control models for such diseases will usefully guide intervention programmes towards their projected endpoints. (imperial.ac.uk)
  • Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa. (lstmed.ac.uk)
  • A new drug developed by an Liverpool School of Tropical Medicine (LSTM) led partnership which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its first in human trial. (growthplatform.org)
  • Lymphatic filariasis (LF) and onchocerciasis are debilitating diseases affecting more than 150 million people globally. (growthplatform.org)
  • Onchocerciasis is the second leading infectious cause of blindness and can cause debilitating and disfiguring skin disease. (cdc.gov)
  • These programs are based on control of the blackfly population and/or mass administration to affected communities of an oral drug called ivermectin (Mectizan™), that is donated by Merck & Co., Inc. As a result of these programs, millions of people are at greatly reduced risk of debilitating itching, disfigurement, and blindness caused by onchocerciasis. (cdc.gov)
  • Chronic ocular onchocerciasis may lead to sclerosing keratitis and iridocyclitis, and finally to blindness. (medscape.com)
  • Despite these efforts, onchocerciasis remains the second leading infectious cause of blindness worldwide. (medscape.com)
  • Diethylcarbamazine is contraindicated as a treatment for onchocerciasis because it leads to microfilarial death and, in some cases, systemic reactions associated with an increased risk for causing blindness in some patients with eye disease. (cdc.gov)
  • Onchocerciasis is the world's second-leading infectious cause of blindness. (openlinksw.com)
  • An estimated 18 million people suffer from onchocerciasis, with approximately 270,000 cases of blindness related to the infection. (openlinksw.com)
  • Unlike in Africa, Yemen has no records of eye complications or blindness due to onchocerciasis. (who.int)
  • Onchocerciasis causes sever itching, skin damage ("onchodermatitis" or "reactive onchodermatitis") and eye lesions eventually leading to visual impairment and permanent blindness. (who.int)
  • Onchocerciasis is a chronic parasitic infection that primarily affects the skin and eyes, leading to severe itching, skin disfigurement, and potentially blindness, greatly impacting the quality of life and economic productivity in endemic areas. (who.int)
  • One of the most severe effects of Onchocerciasis is eye disease, which can lead to visual impairment and ultimately blindness. (who.int)
  • Efforts to control Onchocerciasis focus on eliminating the blackfly vector through insecticide spraying and on mass drug administration, mainly with ivermectin, which kills the larvae, and prevents blindness. (who.int)
  • As the common name suggests, infection of the eye by onchocerciasis can lead to vision loss and eventually blindness. (rareguru.com)
  • A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. (outbreaknewstoday.com)
  • Onchocerciasis, caused by the parasitic nematode, Onchocerca volvulus afflicts some 37 million people worldwide, and is the second leading infectious cause of blindness globally. (biomedcentral.com)
  • Abstract on The African Programme for Onchocerciasis Control (APOC), which was launched in 1995 for the ultimate purpose of eliminating human onchocerciasis from the African countries in which the disease was endemic. (mectizan.org)
  • Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. (bvsalud.org)
  • Onchocerciasis is an infection caused by the parasitic worm Onchocerca volvulus , spread by the bite of an infected Simulium blackfly. (cdc.gov)
  • Onchocerciasis is a dermatitis in equines and ruminants caused by microfilariae produced by adult Onchocerca . (merckvetmanual.com)
  • Onchocerciasis is caused by the parasitic worm Onchocerca volvulus . (who.int)
  • We are using these data to help us understand density-dependent processes involved in the transmission dynamics of Onchocerca volvulus with the results being used to parameterise mathematical models of onchocerciasis transmission and control. (imperial.ac.uk)
  • Onchocerciasis is infection with the roundworm Onchocerca volvulus . (msdmanuals.com)
  • Equine onchocerciasis is a parasitic disease of horses worldwide, caused by a filarial worm of the genus Onchocerca . (horsedvm.com)
  • Equine Onchocerciasis 17 Prior descriptions of the equine nuchal ligament infected with Onchocerca sp. (fliphtml5.com)
  • Equine onchocerciasis is a parasitic infection of horses, with world-wide distribu-tion, caused by a filiarial worm of the genus Onchocerca. (fliphtml5.com)
  • Repeated treatments with ivermectin have been delivered using the annual community directed treatment with ivermectin (CDTI) approach for several years to control onchocerciasis in some Loa loa-Onchocerca volvulus co-endemic areas. (lstmed.ac.uk)
  • Onchocerciasis is the result of infection by the filarial Onchocerca volvulus. (rajeevclinic.com)
  • Onchocerciasis drug discovery studies have so far been based on in vivo models using Onchocerca species which are not the closest to O. volvulus, and which may therefore, not adequately mimic the natural infection in humans. (biomedcentral.com)
  • Onchocerciasis is a neglected tropical disease caused by the filarial nematode, Onchocerca volvulus . (biomedcentral.com)
  • BackgroundIn onchocerciasis endemic areas in Africa, heterogenous biting rates by blackfly vectors on humans are assumed to partially explain age- and sex-dependent infection patterns with Onchocerca volvulus. (worktribe.com)
  • The American programme(OEPA) operating in onchocerciasis epidemiological settings similar to the mild end of the complex epidemiology of onchocerciasis in Africa, has succeeded in eliminating onchocerciasis from 4 of its 6 endemic countries. (biomedcentral.com)
  • However, the worldwide burden of onchocerciasis has been considerably reduced as the result of very successful disease control programs led by the World Health Organization (WHO). (cdc.gov)
  • Since 1975, the WHO, international foundations, nongovernmental organizations, and governments have worked cooperatively to reduce the burden of onchocerciasis. (medscape.com)
  • Ethiopia is one of the countries with high burden of onchocerciasis in the world. (hindawi.com)
  • The African Program for Onchocerciasis Control (APOC), which supports onchocerciasis control in endemic African countries outside the OCP, applies ivermectin, its principal control tool, to communities in high-risk areas as determined by rapid epidemiological mapping of onchocerciasis (REMO) and Geographic Information Systems (GIS). (qxmd.com)
  • Building on the experience with onchocerciasis elimination of the OCP, APOC has leveraged OCP's vast modelling experience and has developed operational procedures and indicators for evaluating progress towards elimination and stopping ivermectin mass treatment of onchocerciasis in the complex African setting. (biomedcentral.com)
  • Following the closure of APOC in 2015, implementation of onchocerciasis elimination in Africa appears to overlook all the experience that has been accumulated by the African programmes. (biomedcentral.com)
  • The registration in 1987 of ivermectin, a safe and effective microfilaricide suitable for mass treatment of onchocerciasis and given free of charge by the manufacturer, Merck & Co, led to the creation of new onchocerciasis control programmes to cover the rest of Africa outside the OCP through the African Programme for Onchocerciasis Control (APOC) and the Americas through the Onchocerciasis Elimination Programme for the Americas (OEPA) [ 7 , 8 ]. (biomedcentral.com)
  • Canine ocular onchocerciasis: a retrospective review of the diagnosis, treatment, and outcome of 16 cases in New Mexico (2011-2015). (tamu.edu)
  • Features of ocular onchocerciasis usually described in forest and savanna areas were both found in this forest - savanna zone of the DRC. (bvsalud.org)
  • the infection is transmitted in remote rural areas and, unlike malaria, contracting onchocerciasis often requires more than one infectious bite. (cdc.gov)
  • Longitudinal follow up of children showed that during vector control activities by the Onchocerciasis Control Programme (OCP) and in low-level transmission areas, infection persisted at higher levels in children from O. volvulus-positive mothers. (nih.gov)
  • In summary, the dominant risk factor for children to become infected is maternal onchocerciasis, and also age-associated factors will strongly impact on the development of patent O. volvulus infection in offspring. (nih.gov)
  • The population at risk for onchocerciasis infection is estimated to be 1.5 million for the whole country (unpublished data). (bmj.com)
  • About 200 million people are at risk of onchocerciasis infection and more than 99% of the global disease burden is present in Africa [ 2 , 3 ]. (biomedcentral.com)
  • Ivermectin does not kill the adult worms that cause onchocerciasis and therefore it will not cure this type of infection. (medlineplus.gov)
  • If you are taking ivermectin to treat onchocerciasis, additional doses 3, 6, or 12 months later may be necessary to control your infection. (medlineplus.gov)
  • Efficacious small animal models in onchocerciasis for in vivo screens and preclinical studies, capable of closely mimicking the natural infection in humans are an urgent, unmet need. (biomedcentral.com)
  • The estimated high prevalence of onchocerciasis especially in the north west led to the introduction of a vertical ivermectin distribution programme in the area in 1993. (bmj.com)
  • BackgroundA high epilepsy prevalence has been reported in several onchocerciasis-endemic villages along the Mbam and Sanaga river valleys in Cameroon, including Bilomo and Kelleng. (researchportal.be)
  • There was a high prevalence of onchocerciasis -related eye lesions compared with non-onchocercal lesions. (bvsalud.org)
  • Strengthening onchocerciasis elimination efforts in areas with a high prevalence of disease burden is crucial to decrease transmission, morbidity, and mortality. (ox.ac.uk)
  • The Central African Republic is among the 10 major target countries of the Africa Programme for Onchocerciasis Control which coordinates ivermectin mass distribution in 19 African countries. (bmj.com)
  • Although the ONCHOSIM prediction modeling showed that eastern Ethiopia is not suitable for onchocerciasis transmission [ 7 ] this study was conducted to confirm the transmission status with primary parasitological data collection. (hindawi.com)
  • Mean estimates of environmental suitability suggest large areas across West and Central Africa, as well as focal areas of East Africa, are suitable for onchocerciasis transmission, consistent with the presence of current control and elimination of transmission efforts. (shu.ac.uk)
  • The formidable scale of data collection required to map onchocerciasis endemicity across the African continent presents an opportunity to use spatial data to identify areas likely to be suitable for onchocerciasis transmission. (shu.ac.uk)
  • [ 14 , 15 ] Recent estimates suggest that over 220 million people live in areas with onchocerciasis transmission, and as many as 1.15 million people are blind or have reduced vision as a result of the disease. (medscape.com)
  • Onchocerciasis is targeted for elimination defined as verified interruption of transmission by 2030 in at least 12 countries globally. (who.int)
  • Onchocerciasis is mainly found in western part of Ethiopia and there is no evidence of transmission in the east ward. (hindawi.com)
  • Therefore, this study was conducted to map onchocerciasis transmission in those zones. (hindawi.com)
  • However, in 2012, the national onchocerciasis programme objective changed from control to elimination by interruption of transmission until 2020. (hindawi.com)
  • The goal of onchocerciasis elimination by 2020 necessitates the delineation of transmission boundaries of endemic areas and suspected adjacent districts. (hindawi.com)
  • Vector control has been effectively applied in the Onchocerciasis Control Program in West Africa (OCP) with remarkable results, interrupting transmission in most parts of the original Program area. (qxmd.com)
  • The use of ivermectin has given variable results: while ivermectin treatment has been effective in all endemic areas in controlling onchocerciasis as a public health problem, its potential for interrupting transmission is more promising in hypo- and mesoendemic areas. (qxmd.com)
  • However, the Conference also concluded that in most if not all the Americas, and possibly Yemen and some sites in Africa, transmission of onchocerciasis can be eliminated using current tools. (qxmd.com)
  • Although interruption of transmission of onchocerciasis cannot currently be achieved in most of Africa, the Conference recommended that efforts be made to preserve areas in West Africa made free of onchocerciasis transmission through the Onchocerciasis Control Program over the past 25 years. (qxmd.com)
  • Onchocerciasis transmission with ivermectin treatment: How long is mass drug administration needed? (imperial.ac.uk)
  • Though vector control proved very successful in controlling onchocerciasis and even interrupting transmission in the core area of the OCP, the method could not be extended elsewhere because of the high cost of implementation as well as the topography of other areas which made access and aerial spraying of complex breeding sites technically difficult if not outright impossible. (biomedcentral.com)
  • This study seeks to provide subsidies for the monitoring of the onchocerciasis transmission in the country. (fiocruz.br)
  • Ov16 serology was done for children aged 7-10years to assess onchocerciasis transmission. (researchportal.be)
  • Ov16 seropositivity in children indicates ongoing onchocerciasis transmission possibly due to suboptimal control measures. (researchportal.be)
  • Ivermectin, a microfilaricide is the only recommended drug used in many onchocerciasis elimination programs to break the transmission cycle by killing the O. volvulus mf. (biomedcentral.com)
  • Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children. (ox.ac.uk)
  • Efforts are being directed toward the elimination of onchocerciasis transmission in endemic areas with community-directed treatment with ivermectin (CDTI) in Africa, which greatly reduces onchocerciasis-associated disease. (ox.ac.uk)
  • To underpin these assumptions and further improve predictions made by onchocerciasis transmission models, demographic patterns in antibody responses to salivary antigens of Simulium damnosum s.l. are evaluated as a measure of blackfly exposure. (worktribe.com)
  • These measures of antibody acquisition and decay could be incorporated into onchocerciasis transmission models towards informing onchocerciasis control, elimination, and surveillance. (worktribe.com)
  • The Mectizan Donation Program congratulates Yemen for a successful April 2018 mass drug administration (MDA) for onchocerciasis elimination! (iapb.org)
  • Colombia, Ecuador, Mexico, and Guatemala have been declared free of onchocerciasis by the World Health Organization (WHO). (msdmanuals.com)
  • Who is most at risk for onchocerciasis? (cdc.gov)
  • In areas where onchocerciasis and loiasis are co-endemic, CDTI reduces the number of, and microfilaraemia in L. loa-infected individuals, and this, in turn, will help to prevent non-neurological and neurological complications post-ivermectin treatment among CDTI adherents. (lstmed.ac.uk)
  • Or it could be that rare cases of nodding syndrome have been missed in areas where onchocerciasis occurs but at lower frequencies than in these areas. (cdc.gov)
  • Onchocerciasis is one of two diseases among twenty covered by the Neglected Tropical Diseases Department of the World Health Organization (WHO) that has been identified for elimination by 2025 [ 1 ]. (biomedcentral.com)
  • Vision loss was mostly caused by onchocerciasis -related diseases , especially those affecting the anterior segment of the eye . (bvsalud.org)
  • Onchocerciasis is locally transmitted in 31 countries of Africa and in foci in Yemen and South America. (cdc.gov)
  • Onchocerciasis is endemic in Africa, Yemen, and in small foci in Central America and South America. (medscape.com)
  • Currently, onchocerciasis is endemic to 31 African countries, to Yemen, and in localized foci in Brazil and Venezuela. (medscape.com)
  • Whilst onchocerciasis in Africa covers extensive areas and is associated with striking human and fly population migrations and remarkably efficient black fly vectors, in the Americas onchocerciasis is found in limited foci. (qxmd.com)
  • In the remaining hyper and mesoendemic foci in Africa, continued annual distribution of ivermectin will keep onchocerciasis controlled to a point where it is no longer a public health problem or constraint to economic development. (qxmd.com)
  • Onchocerciasis is endemic in sub-Saharan Africa, Yemen and a few foci in Central and South America. (rajeevclinic.com)
  • Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. (shu.ac.uk)
  • 19: 16-22 (1982) Equine Onchocerciasis:Lesions in the Nuchal Ligament of Midwestern U.S. Horses G. M. SCHMIDTJ. (fliphtml5.com)
  • The presentations underlined epidemiological and entomological differences between onchocerciasis in Africa and the Americas. (qxmd.com)
  • Simplified life cycle of Onchocerciasis volvulus. (medscape.com)
  • Therefore, this study was carried out to develop a better drug screening model for onchocerciasis, based on the use of cow-derived O. ochengi , the closest known relative of O. volvulus . (biomedcentral.com)
  • Onchocerciasis causes high morbidity, psychosocial problems, and reduced agricultural productivity [ 3 ]. (hindawi.com)
  • Chronic skin onchocerciasis (onchodermatitis) causes itching, a rash with small pimples (papular rash), scarring, and thickened, leathery skin (lichenification). (rareguru.com)
  • In June 2021, a two-phase survey of epilepsy was conducted in selected villages in Mundri West and East Counties, an onchocerciasis-endemic area in Western Equatoria State in South Sudan. (elrha.org)
  • The effectiveness of the MosqTent® trap was evaluated in endemic area to onchocerciasis in Brazil. (fiocruz.br)
  • When a blackfly bites a person who has onchocerciasis, microscopic worm larvae (called microfilariae) in the infected person's skin are ingested by the blackfly. (cdc.gov)
  • In the Eastern Mediterranean Region, onchocerciasis is transmitted in Yemen and Sudan with an estimated one million people requiring preventative treatment in 2018. (who.int)
  • In 2007, the Elimination Policy was launched with an objective to eliminate Onchocerciasis through bi-annual treatment with Ivermectin using community directed treatment strategy and/or vector control/elimination. (health.go.ug)
  • In the Americas, through support of the Onchocerciasis Elimination Program in the Americas (OEPA), a strategy of bi-annual ivermectin treatment of at least 85% of the eligible populations in all endemic communities is showing very good results and promises to be effective in eliminating onchocerciasis in the region.The Conference concluded that onchocerciasis is not eradicable using current tools due to the major barriers to eradication in Africa. (qxmd.com)
  • If onchocerciasis causes symptoms, treatment is a single dose of ivermectin , which is repeated every 6 to 12 months until symptoms are gone. (msdmanuals.com)
  • Moxidectin (Mox) was approved by the U.S. FDA in June 2018 for treatment of onchocerciasis in persons at least 12 years of age. (wustl.edu)
  • Crucially, 6-monthly administration of ivermectin in school-age children at risk of onchocerciasis-associated epilepsy could be achieved by supplementing annual CDTI with an extra round of ivermectin treatment during Child Health Days in schools and/or other distribution sites every year. (ox.ac.uk)
  • The list of 31 African countries can be found on the World Health Organization (WHO) Onchocerciasis Fact Sheet external icon external icon website. (cdc.gov)
  • Four countries have been verified by the World Health Organization as free from onchocerciasis: Colombia, Ecuador, Mexico, and Guatemala. (cdc.gov)
  • Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa? (worktribe.com)
  • Despite high rates, less than half of people participating in the study took ivermectin (a control strategy for onchocerciasis which causes epilepsy) during the last distribution round in 2021. (elrha.org)
  • Urgent action is needed to prevent children from developing onchocerciasis-associated epilepsy by strengthening the local onchocerciasis-elimination programme. (elrha.org)
  • Previously published diagnostic criteria for onchocerciasis-associated epilepsy (OAE) were used. (researchportal.be)
  • According to the results of rapid epidemiological assessments, the whole of the Central African Republic is endemic for onchocerciasis. (bmj.com)
  • It employed vector control and accumulated lots of knowledge on the dynamics of onchocerciasis elimination over a wide range of epidemiological settings in the vast expanse of its core area. (biomedcentral.com)
  • The north west, including the district of Bossangoa, shows the highest levels of endemicity of onchocerciasis, as well as being the most densely populated region of the country. (bmj.com)
  • Onchocerciasis is commonly treated with an oral medicine called ivermectin. (cdc.gov)
  • If the Mox combination treatments are safe and superior to the comparators for clearing Mf, they could improve chances for LF elimination in areas of Africa that are coendemic for LF and onchocerciasis (without loiasis ). (wustl.edu)
  • Onchocerciasis is a rare tropical parasitic disease transmitted by a black fly. (rareguru.com)
  • To determine baseline data regarding eye lesions and vision loss in five villages of Lusambo, an onchocerciasis -hyperendemic forest - savanna area in the Democratic Republic of Congo (DRC), in preparation of mass ivermectin distribution. (bvsalud.org)
  • Methodology/Principal findingsRecently developed IgG and IgM anti-saliva immunoassays for S. damnosum s.l. were applied to blood samples collected from residents in four onchocerciasis endemic villages in Ghana. (worktribe.com)
  • Large scale control of onchocerciasis started in 1974 with the creation of the Onchocerciasis Control Programme in West Africa (OCP) [ 6 ]. (biomedcentral.com)
  • Although elimination of onchocerciasis with ivermectin was considered feasible only in the Americas, recently it has been shown possible in Africa too, necessitating fundamental changes in technical and operational approaches and procedures. (biomedcentral.com)
  • Brasil / Onchocerciasis Elimination Program for the Americas. (fiocruz.br)
  • Humans acquire onchocerciasis through the bite of Simulium blackflies. (medscape.com)
  • Humans acquire onchocerciasis through the bite of Simulium blackflies (see image below). (medscape.com)
  • The program works closely with partners in the control and elimination of Onchocerciasis. (health.go.ug)
  • The national onchocerciasis programme started in 2001 with the objective of controlling the disease to the level below public health importance. (hindawi.com)
  • In 2008, the Directing Council of PAHO / WHO approved Resolution CD48.R12, which established the objective of eliminating onchocerciasis by 2012. (paho.org)
  • Initially its objective was to control onchocerciasis as a public health problem but that objective was later expanded to include the elimination of onchocerciasis where feasible. (biomedcentral.com)
  • The OCP applied vector control to achieve its objective of eliminating onchocerciasis as a public health problem and as an obstacle to socio-economic development in the West African countries involved. (biomedcentral.com)
  • Panelists will share the long history of the onchocerciasis control effort, including the diverse, steadfast partnerships that made it possible, as well as lessons learned and best practices to achieve elimination of the disease over the near future. (gghalliance.org)
  • These strategies would help achieve the elimination of onchocerciasis and its associated disease burden. (ox.ac.uk)
  • The National Onchocerciasis Control program was established in 1992 to undertake programs aimed at controlling and eliminating Onchocerciasis as a public health problem in Uganda. (health.go.ug)
  • Profile of eye lesions and vision loss: a cross-sectional study in Lusambo, a forest-savanna area hyperendemic for onchocerciasis in the Democratic Republic of Congo. (bvsalud.org)
  • Results of search for 'su:{Onchocerciasis. (who.int)
  • Our findings support the existence of OAE in Cameroon and highlight the need to strengthen onchocerciasis elimination programs. (researchportal.be)